21 May 2009
Quality of life after living kidney donation in Poland – experience of one centre
M Bieniasz, A Kwiatkowski, P Domagała, R Kieszek, J Gozdowska, A Jakubowska- -Winecka, J Trzebicki, A Darocha, A Deptuła, L Pączek, M Durlik, A ChmuraAnn Transplant 2009; 14(1): 53-53 :: ID: 880394
Abstract
Background: Kidney transplantation is the best treatment of end-stage renal
disease. The benefits for recipients are obvious. The consequences for the
living kidney donors appear to be not so clear. The objective of this study was to evaluate the quality of life after living kidney donation.
Material/Methods: A total of 66 living donor open nephrectomies were
performed in the Department of General and Transplantation Surgery at the Warsaw Medical University between 1995 and 2005. The quality of life was assessed in 32 donors after the nephrectomy. The study applied The Satisfaction with Life Scale (SWLS) developed by Ed Diener and colleagues
(Diener, Emmons, Larsen and Griffin, 1985) adapted in Poland by Juczynski and the questionnaire formulated by Jakubowska-Winiecka, Bieniasz and Domagala. Donor mean age was 46.3 years (range 31-69). Observation period ranged from 36 to 156 months after donation.
Results: The mean SWLS score in the investigated group was 22.8 (men - 21.5, women - 23.9). Mean life satisfaction in living kidney donors was comparable to the general population in Poland. Neither of the donors regretted their decision about kidney donation. Mean pain score after donation was 3.2 in 5-item scale (1-severe pain, 5-mild pain). Medical care was 4.4 and 4.5 in 5-item scale (1-poor, 5-very good) before and after donation, respectively. Mean time of returning to work was 3.5 months.
Conclusions: Living kidney donation in Poland has no significant impact on the donor's quality of life.
Keywords: Kidney Transplantation, Living Donors
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






